CD274 and neoplasm: In the case of ex vivo neuroblastoma organoids, histone deacetylase inhibitors have shown the ability to alleviate the immunosuppressive microenvironment by down‐regulating PD‐L1 expression and up‐regulating MHC‐I expression in tumour cells.